Concepedia

Sujana Movva

SM

Statistics

Publications

45

Citations

4.6K

H-Index

26

Active since

1994

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Fox Chase Cancer Center

Cornell University

The University of Texas MD Anderson Cancer Center

Washington University in St. Louis

Sujana Movva is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and malignant neoplasms.

ORCID

Publications per year

1994–2024

45

Publications

45

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack et al. · The Lancet Oncology · 2017 · 1.4K citations · Full text

, , +13

Sorafenib for Advanced and Refractory Desmoid Tumors

Mrinal M. Gounder, Michelle R. Mahoney, Brian A. Van Tine et al. · New England Journal of Medicine · 2018 · 449 citations · Full text

, , +14

NCCN Guidelines Insights: Bone Cancer, Version 2.2017

J. Sybil Biermann, Warren Chow, Damon R. Reed et al. · Journal of the National Comprehensive Cancer Network · 2017 · 299 citations · Full text

, , +15

PRIMARY BRAIN TUMORS IN ADULTS

Sreenivasa R Chandana, Sujana Movva, Madan L. Arora et al. · CONTINUUM Lifelong Learning in Neurology · 1994 · 239 citations

, , +17

FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

Eileen Shi, Juliann Chmielecki, Chih‐Min Tang et al. · Journal of Translational Medicine · 2016 · 233 citations · Full text

, , +17

1–5 of 45